HK shares easier, discounts Sinopharm's debut gain

HONG KONG, Sept 23 (Reuters) - Hong Kong shares ended lower
on Wednesday as investors began to discount Sinopharm's (1099.HK)
debut gains and on expectations that the U.S. Federal Reserve
will keep its policy rate unchanged.

But the market stayed within a narrow range, and is expected
to find clearer direction when the Fed announces its rate
decision and the latest economic conditions.

The benchmark Hang Seng Index .HSI slipped 0.49 percent to
21,595.52, off Thursday's 13-month high.

The China Enterprises Index .HSCE of top locally listed
mainland Chinese stocks slipped 0.64 percent to 12,431.81.
(Reporting by Nerilyn Tenorio; Editing by Chris Lewis)